| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Lilly Research Laboratories, Departments of Cardiovascular Research (T.H., P.F., J.V.F., M.C., G.C., P.E., L.F.M.), Endocrinology (A.S., M.D.M.), Toxicology (H.G., T.R.), Integrative Biology (S.L.), Eli Lilly & Co., Indianapolis, Indiana 46285
Address all correspondence and requests for reprints to: Dr. Laura F. Michael, Eli Lilly & Co., Cardiovascular Research, DC 0520, Indianapolis, Indiana 46285. E-mail: laura_michael{at}lilly.com.
Peroxisomes are the exclusive site for the ß-oxidation of very-long-chain fatty acids of more than 20 carbons in length (VLCFAs). Although the bulk of dietary long-chain fatty acids are oxidized in the mitochondria, VLCFAs cannot be catabolized in mitochondria and must be shortened first by peroxisomal ß-oxidation. The regulation of peroxisomal, mitochondrial, and microsomal fatty acid oxidation systems in liver is mediated principally by peroxisome proliferator-activated receptor
(PPAR
). In this study we provide evidence that the liver X receptor (LXR) regulates the expression of the genetic program for peroxisomal ß-oxidation in liver. The genes encoding the three enzymes of the classic peroxisomal ß-oxidation cycle, acyl-coenzyme A (acyl-CoA) oxidase, enoyl-CoA hydratase/L-3-hydroxyacyl-CoA dehydrogenase, and 3-ketoacyl-CoA thiolase, are activated by the LXR ligand, T0901317. Accordingly, administration of T0901317 in mice promoted a dose-dependent and greater than 2-fold increase in the rate of peroxisomal ß-oxidation in the liver. The LXR effect is independent of PPAR
, because T0901317-induced peroxisomal ß-oxidation in the liver of PPAR
-null mice. Interestingly, T0901317-induced peroxisomal ß-oxidation is dependent on the LXR
isoform, but not the LXRß isoform. We propose that induction of peroxisomal ß-oxidation by LXR agonists may serve as a counterregulatory mechanism for responding to the hypertriglyceridemia and liver steatosis that is promoted by potent LXR agonists in vivo; however, additional studies are warranted.
This article has been cited by other articles:
![]() |
B. M. Stenson, M. Ryden, K. R. Steffensen, K. Wahlen, A. T. Pettersson, J. W. Jocken, P. Arner, and J. Laurencikiene Activation of Liver X Receptor Regulates Substrate Oxidation in White Adipocytes Endocrinology, September 1, 2009; 150(9): 4104 - 4113. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, P. M. Rogers, K. R. Stayrook, C. Su, G. Varga, Q. Shen, S. Nagpal, and T. P. Burris The Selective Alzheimer's Disease Indicator-1 Gene (Seladin-1/DHCR24) Is a Liver X Receptor Target Gene Mol. Pharmacol., December 1, 2008; 74(6): 1716 - 1721. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, P. M. Rogers, C. Su, G. Varga, K. R. Stayrook, and T. P. Burris Regulation of Cholesterologenesis by the Oxysterol Receptor, LXR{alpha} J. Biol. Chem., September 26, 2008; 283(39): 26332 - 26339. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Musso, R. Gambino, F. De Michieli, G. Biroli, A. Premoli, G. Pagano, S. Bo, M. Durazzo, and M. Cassader Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake Am. J. Clinical Nutrition, September 1, 2007; 86(3): 661 - 671. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |